These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 371028)

  • 1. The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine in ventricular ectopic activity.
    Myburgh DP; Goldman AP
    S Afr Med J; 1978 Dec; 54(25):1053-5. PubMed ID: 371028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
    Böcker K; Köhler E; Seipel L; Loogen F
    Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of perhexiline maleate on ventricular ectopic activity.
    Myburgh DP
    S Afr Med J; 1978 Apr; 53(13):499-501. PubMed ID: 354034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide].
    Romanò M; Spinelli A; Cazzani E; Muzio L
    Clin Ter; 1991 Jul; 138(1):13-9. PubMed ID: 1834395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease.
    Gitlin N
    S Afr Med J; 1975 Nov; 49(51):2115-7. PubMed ID: 54942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
    Wester HA; Mouselimis N
    Dtsch Med Wochenschr; 1982 Aug; 107(34):1262-6. PubMed ID: 6809442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats.
    Sakurada H; Motomiya T; Hiraoka M
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():835-41. PubMed ID: 1718397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
    Tanabe T; Yoshikawa H; Furuya H; Goto Y
    Jpn Circ J; 1988 Mar; 52(3):298-305. PubMed ID: 3373722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined anti-arrhythmic therapy with class 1 and class 3 drugs.
    James MA; Papouchado P; Jones JV
    Postgrad Med J; 1989 Aug; 65(766):519-24. PubMed ID: 2513563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.